Catherine A. Schnabel

Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population

Dennis C. Sgroi, Ivana Šestak, Jack Cuzick et al. · The Lancet Oncology · 2013 · 394 citations · Full text

Medicine, Oncology, Breast Oncology +14

Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor–Positive Breast Cancer

Ivana Šestak, Richard Buus, Jack Cuzick et al. · JAMA Oncology · 2018 · 330 citations · Full text

Medicine, Oncology, Breast Oncology +14

CREB Binding Protein Interacts with Nucleoporin-Specific FG Repeats That Activate Transcription and Mediate NUP98-HOXA9 Oncogenicity

Lawryn H. Kasper, Paul K. Brindle, Catherine A. Schnabel et al. · Molecular and Cellular Biology · 1999 · 323 citations

Medicine, Cancer Biology, Molecular Biology +15

Trimeric Association of Hox and TALE Homeodomain Proteins Mediates <i>Hoxb2</i> Hindbrain Enhancer Activity

Yakop Jacobs, Catherine A. Schnabel, Michael L. Cleary · Molecular and Cellular Biology · 1999 · 249 citations · Full text

Life Sciences, Developmental Biology, Molecular Biology +17

Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker

Dennis C. Sgroi, Erin Carney, Elizabeth Zarrella et al. · JNCI Journal of the National Cancer Institute · 2013 · 232 citations · Full text

Medicine, Oncology, Pharmacology +17